ANP32A-mediated histone 3 K27 acetylation is essential for sotorasib activity in KRAS-mutant non–small cell lung cancer
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2025.111110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Kailing Pan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Affiliated Jinhua Hospital of Zhejiang University School of Medicine, Jinhua, China; Central Laboratory and Pre…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Proto-Oncogene Proteins p21(ras), Histones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science and Technology Project of Zhejiang Province, Jinhua City Science and Technology Bureau, Science and Technology Department of Zhejiang Province.
Abstract (Originalsprache)
Drug resistance is a major challenge for the target therapy of KRAS-mutant non-small cell lung cancer (NSCLC). Here, we observe that ANP32A is tightly associated with KRAS-mutant NSCLC and serves as an unfavorable prognosis factor. ANP32A deficiency impaired cell proliferation, migration, invasion, and cell cycle progression and induced sotorasib (Sot) resistance in KRAS-mutant NSCLC cells, which were reversed by ANP32A reoverexpression in ANP32A-deficient cells. Mechanistically, ANP32A deficiency impaired histone 3 acetylation at lysine 27 (H3K27Ac). Particularly, ANP32A deficiency reduced H3K27Ac of the YEATS4 gene promoter and downregulated YEATS4 expression. ANP32A also interacted with YEATS4 and promoted its binding to H3K27Ac. Furthermore, YEATS4 overexpression partially restored ANP32A deficiency-impaired cell proliferation, H3K27Ac, and Sot sensitivity. Most importantly, trichostatin A mimicked the effect of ANP32A, which restored YEATS4 expression, antagonized Sot resistance, and resensitized ANP32A-deficient cells to Sot in vitro and in vivo, possibly by reactivating the p53 pathway. Our study identifies a new epigenetic mechanism involving the ANP32A that promotes KRAS-mutant lung cancer growth and affects Sot activity. The combination of Sot and histone deacetyltransferase inhibitors could be an effective treatment for KRAS-mutant lung cancer. ANP32A may serve as a biomarker for Sot treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Affiliated Jinhua Hospital of Zhejiang University School of Medicine, Jinhua, China; Central Laboratory and Precision Medicine Center, Affiliated Jinhua Hospital of Zhejiang Univers…
- College of Life Sciences, Hubei Key Laboratory of Cell Homeostasis, Wuhan University, Wuhan, Hubei, China.
- Department of Cardiothoracic Surgery, Affiliated Jinhua Hospital of Zhejiang University School of Medicine, Jinhua, China.
- College of Life Sciences, Hubei Key Laboratory of Cell Homeostasis, Wuhan University, Wuhan, Hubei, China. Electronic address: z-huang@whu.edu.cn.
- Department of Cardiothoracic Surgery, Affiliated Jinhua Hospital of Zhejiang University School of Medicine, Jinhua, China; Jinhua Key Laboratory of Cancer Nutrition and Metabolism Research, Jinhua Municipal Central Hosp…
Förderung
- Medical Science and Technology Project of Zhejiang Province
- Jinhua City Science and Technology Bureau
- Science and Technology Department of Zhejiang Province
- Zhejiang Province Natural Science Foundation
Zitieren
APA
Pan, K., Dang, M., Xu, B., Huang, Z., & Chen, X. (2026). ANP32A-mediated histone 3 K27 acetylation is essential for sotorasib activity in KRAS-mutant non–small cell lung cancer. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.111110
Vancouver
Pan K, Dang M, Xu B, Huang Z, Chen X. ANP32A-mediated histone 3 K27 acetylation is essential for sotorasib activity in KRAS-mutant non–small cell lung cancer. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2025.111110
BibTeX
@article{Pan2026,
author = {Pan, Kailing and Dang, Mingjing and Xu, Bo and Huang, Zan and Chen, Xianguo},
title = {ANP32A-mediated histone 3 K27 acetylation is essential for sotorasib activity in KRAS-mutant non–small cell lung cancer},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2025.111110}
}
EUVIMED